Whole-body hyperthermia at the DGHT conference in Berlin



DGHT-Kongress 1
Dr. Sebastian Zschaeck, from Charité University Berlin, Department of Radiooncology, reviewed the clinical data of fever-range WBH, emphasizing the need for more clinical studies, also planned at Charité University. He reported preliminary results of the ongoing study Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer.
DGHT-Kongress 1
Dr. Stefan Hiller and Brigitte Deckers, from Filderklinik near Stuttgart, gave an overview of the principles of integrative oncology in an anthroposophic hospital and reported their use of fever-range whole-body hyperthermia. It is used in palliative, as well as in adjuvant settings, usually approximately 1 treatment per month. Main aims are the mitigation of side-effects of chemotherapy and the stimulation of anti-cancer immune surveillance.
DGHT-Kongress 1
Dr. Kay-U. Hanusch, from Emmenspital, in Switzerland reported a systematic review of 7 studies and 148 subjects on The impact of whole-body hyperthermia interventions on mood and depression, published OPEN ACCESS in the International Journal of Hyperthermia Volume 36, 2019 - Issue 1

Print Email

heckel medizintechnik GmbH

Olgastrasse 25
73728 Esslingen

Tel: ++49 (0)711 - 128989 - 0
Fax: ++49 (0)711 - 128989 - 20



Visit us on Facebook

Visit us on Linkedin





We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.